EP300 and cancer: We used an established mini-gene assay (“Methods”) to experimentally examine the splicing alterations generated by five selected nc-SCMs in cancer-related genes21, namely, EP300, BCOR, DNMT3A, KMT2B, and MAP3K1 (Fig. 6a), which play important roles in cancer initialization and progression.